Mikayel Movsisyan

Title: Mikayel Movsisyan: Innovator in Pharmaceutical Synthesis

Introduction

Mikayel Movsisyan is a prominent inventor based in Yerevan, Armenia. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the synthesis of important compounds. His work is characterized by innovative approaches that enhance the efficiency and effectiveness of drug development.

Latest Patents

Movsisyan holds a patent for a novel process for the synthesis of buprenorphine. This invention outlines a unique route for producing the opioid receptor antagonist buprenorphine or its pharmaceutically acceptable salts, starting from thebaine. The process involves several key steps, including the reaction of thebaine with a dienophile, alkylation using a Grignard reagent, and the formation of a cyanamide. The method also includes deprotection steps and derivatization, ultimately leading to the production of buprenorphine.

Career Highlights

Mikayel Movsisyan is currently associated with Azad Pharma AG, where he applies his expertise in pharmaceutical synthesis. His innovative work has positioned him as a valuable asset in the field, contributing to advancements in drug formulation and development.

Collaborations

Movsisyan collaborates with Tamar Danielyan, enhancing the research and development efforts at Azad Pharma AG. Their partnership exemplifies the importance of teamwork in driving innovation within the pharmaceutical industry.

Conclusion

Mikayel Movsisyan's contributions to the synthesis of buprenorphine highlight his role as an innovator in pharmaceutical chemistry. His work not only advances drug development but also showcases the potential for innovative approaches in the field.